当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 现金流量表

东诚药业

(002675)

  

流通市值:96.57亿  总市值:107.12亿
流通股本:7.43亿   总股本:8.25亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金608,119,198.82,767,898,800.962,095,780,834.071,425,303,428.45
  收到的税费返还3,516,592.1265,836,787.6958,599,504.8939,053,045.54
  收到其他与经营活动有关的现金17,050,594.3745,418,554.7148,611,095.5528,175,199.67
  经营活动现金流入小计628,686,385.292,879,154,143.362,202,991,434.511,492,531,673.66
  购买商品、接受劳务支付的现金279,638,296.38994,764,300.59803,640,810.39520,393,984.23
  支付给职工以及为职工支付的现金182,675,820.95515,676,516.61410,403,134.24286,060,350.49
  支付的各项税费64,952,979.81266,899,287.61202,197,140.59146,662,515.74
  支付其他与经营活动有关的现金132,817,819.68521,963,644.09445,756,021.72271,808,548.15
  经营活动现金流出小计660,084,916.822,299,303,748.91,861,997,106.941,224,925,398.61
  经营活动产生的现金流量净额-31,398,531.53579,850,394.46340,994,327.57267,606,275.05
二、投资活动产生的现金流量:
  收回投资收到的现金260,500,0001,144,840,000884,840,000522,000,000
  取得投资收益收到的现金1,024,660.624,760,198.074,076,770.732,938,148.73
  处置固定资产、无形资产和其他长期资产收回的现金净额50541,740.868,761,687.064,152,581.34
  处置子公司及其他营业单位收到的现金净额--115.49--
  收到的其他与投资活动有关的现金818,333.751,320,000220,000-
  投资活动现金流入小计262,343,044.371,151,461,823.44897,898,457.79529,090,730.07
  购建固定资产、无形资产和其他长期资产支付的现金74,296,959.11360,817,831.77202,127,232.34162,407,869.39
  投资支付的现金208,000,0001,345,023,879.451,046,437,917.94669,485,479.45
  支付其他与投资活动有关的现金-294,500255,115.49115.49
  投资活动现金流出小计282,296,959.111,706,136,211.221,248,820,265.77831,893,464.33
  投资活动产生的现金流量净额-19,953,914.74-554,674,387.78-350,921,807.98-302,802,734.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金-416,981,732.68426,160,000230,160,000
  取得借款收到的现金159,689,298.6486,974,381.3464,343,346375,969,993.41
  收到其他与筹资活动有关的现金2,200,00024,270,00024,054,220.6126,829,220.61
  筹资活动现金流入小计161,889,298.6928,226,113.98914,557,566.61632,959,214.02
  偿还债务支付的现金56,602,165.54704,906,078.12578,270,532.14540,939,397.81
  分配股利、利润或偿付利息支付的现金16,827,553.83110,368,705.9390,095,905.2174,498,623.67
  支付其他与筹资活动有关的现金88,493,722.4626,630,589.9317,306,698.0213,724,400.23
  筹资活动现金流出小计161,923,441.83841,905,373.98685,673,135.37629,162,421.71
  筹资活动产生的现金流量净额-34,143.2386,320,740228,884,431.243,796,792.31
四、汇率变动对现金及现金等价物的影响-2,501,209.53-2,391,921.442,482,833.66,625,400.82
五、现金及现金等价物净增加额-53,887,799.03109,104,825.24221,439,784.43-24,774,266.08
  加:期初现金及现金等价物余额847,078,806.23735,620,565.08735,620,565.08735,620,565.08
  期末现金及现金等价物余额793,191,007.2844,725,390.32957,060,349.51710,846,299
补充资料:
  净利润-154,441,271.11-70,039,313.7
  资产减值准备-15,055,905.42-7,556,002.72
  固定资产和投资性房地产折旧-165,039,794.1-80,090,433.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-165,039,794.1-80,090,433.86
  无形资产摊销-15,669,917.96-8,468,534
  长期待摊费用摊销-21,095,513.48-8,759,079
  处置固定资产、无形资产和其他长期资产的损失--82,376.19--194,231.24
  固定资产报废损失-412,212.94-71,479.95
  公允价值变动损失--904,860.26-610,065.75
  财务费用-141,044,793.07-56,134,167.63
  投资损失-16,781,001.75-6,374,584.07
  递延所得税--34,855,149.38--14,271,863.04
  其中:递延所得税资产减少--39,991,180.97--13,696,532.37
    递延所得税负债增加-5,136,031.59--575,330.67
  存货的减少-112,133,031.08-16,832,512.54
  经营性应收项目的减少--53,994,851.18--45,882,705.2
  经营性应付项目的增加-14,179,891.37-51,269,852.49
  其他--4,226,065.2-11,829,034.35
  现金的期末余额-844,725,390.32-710,846,299
  减:现金的期初余额-735,620,565.08-735,620,565.08
  现金及现金等价物的净增加额-109,104,825.24--24,774,266.08
公告日期2026-04-282026-03-262025-10-292025-08-15
审计意见(境内)标准无保留意见
TOP↑